Home
CHUYÊN ĐỀ
Issue: Số 100, 2022
Article
PGS.TS. PHẠM MẠNH HÙNG: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
ThS.BS.Nguyễn Minh Hùng: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
References
1.
1. van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011;58:2241-7.
2.
2. Baumgartner H., De Backer JD, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645.
3.
3. Engelfriet PM, Duffels MG, Moller T, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 2007;93:682-7.
4.
4. Vogel M, Berger F, Kramer A, et al. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 1999;82:30-3.
5.
5. Yong G, Khairy P, De Guise P, et al. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv 2009;2:455-62.
6.
6. Steele PM, Fuster V, Cohen M, et al. Isolated atrial septal defect with pulmonary vascular obstructive disease--long- term follow-up and prediction of outcome after surgical correction. Circulation 1987;76:1037-42.
7.
7. Craig RJ, Selzer A. Natural History and Prognosis of Atrial Septal Defect. Circulation 1968;37:805-15.
8.
Konstantinides S, Geibel A, Olschewski M, et al. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 1995;333:469-73.
9.
8. Hörer J, Muller S, Schreiber C, et al. Surgical closure of atrial septal defect in patients older than 30 years: risk factors for late death from arrhythmia or heart failure. Thorac Cardiovasc Surg 2007;55:79-83.
10.
9. Vasan RS, Shrivastava S, Kumar MV. Value and limitations of Doppler echocardiographic determination of mitral valve area in Lutembacher syndrome. J Am Coll Cardiol 1992;20:1362-70.
11.
10. Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation 2006;114:1645-53.
12.
11. Lutembacher R. De la sténose mitrale avec communication interauriculaire. Arch Mal Coeur 1916;9:237-60.
13.
12. PerloffJK.TheClinicalRecognition ofCongenitalHeartDisease,4thedition.Philadelphia:Saunders, 1994:323-8.
14.
13. Ruiz CE, Gamra H, Mahrer P, et al. Percutaneous closure of a secundum atrial septal defect and double balloon valvotomies of a severe mitral and aortic valve stenosis in a patient with Lutembacher’s syndrome and severe pulmonary hypertension. Cathet Cardiovasc Diagn 1992;25:309-12.
15.
14. Joseph G, Rajpal KA, Kumar KS. Definitive percutaneous treatment of Lutembacher’s syndrome. Catheter Cardiovasc Interv 1999; 48:199-204.
16.
15. Chau EM, Lee CH, Chow WH. Transcatheter treatment of a case of Lutembacher syndrome. Catheter Cardiovasc Interv 2000;50:68-70.
17.
16. Ledesma M, Martinez P, Cázares MA, et al. Transcatheter treatment of Lutembacher syndrome: Combined balloon mitral valvuloplasty and percutaneous atrial septal defect closure. J Invasive Cardiol 2004;16:678-9.
18.
17. Aminde LN, Dzudie A, Takah NF, et al. Current diagnostic and treatment strategies for Lutembacher syndrome: the pivotal role of echocardiography. Cardiovasc Diagn Ther 2015;5:122-32.
19.
18. Jategaonkar S, Scholtz W, Schmidt H, etal. Percutaneous closureofatrialseptal defects: echocardiographic and functional results in patients older than 60 years. Circ Cardiovasc Interv 2009;2:85-9
20.
19. Holzer R, Qi-Ling C, Hijazi ZM. Closure of a moderately large atrial septal defect with a self-fabricated fenestrated Amplatzer septal occluder in an 85-year-old patient with reduced diastolic elasticity of the left ventricle. Catheter Cardiovasc Interv 2005;64:513-518.
21.
20. Humenberger M, Rosenhek R, Gabriel H, et al. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J 2011;32:553-60.
22.
21. Bruch L, Winkelmann A, Sonntag S, Scherf F, Rux S, Grad MO, Kleber FX. Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and/or right heart failure. J Interv Cardiol 2008;21:44-9.
23.
22. Warnes CA, Williams RG, Bashore TM, et al. ACC/ AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e143-263.
24.
23. Beghetti M, Galie N, Bonnet D. Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality? Congenit Heart Dis 2012;7:3-11.
25.
24. Viswanathan S, Kumar RK. Assessment of Operability of Congenital Cardiac Shunts with Increased Pulmonary Vascular Resistance. Catheter Cardiovasc Interv 2008;71:665-70.
26.
25. Virmani R, Roberts WC. Pulmonary arteries in congenital heart disease: a structure-function analysis. In: Roberts WC. editor. Adult congenital heart disease. 1st ed. Philadelphia, PA: Davis, 1987:77-130.
27.
26.Toscano Barboza E, Brandenburg RO, Swan HJ. Atrial septal defect: the electrocardiogram and its hemodynamic correlation in 100 proved cases. Am J Cardiol 1958;2:698-713.
28.
27. Laksmivenkateshiah S, Singhi AK, Vaidyanathan B, et al. Decline in arterial partial pressure of oxygen after exercise: a surrogate marker of pulmonary vascular obstructive disease in patients with atrial septal defect and severe pulmonary hypertension. Cardiol Young 2011;21:292-8.
29.
28. Wilkinson JL. Congenital heart disease: hemodynamic calculations in the catheter laboratory. Heart 2001;85:113-20.
30.
29. de Vecchi A, Clough RE, Gaddum NR, et al. Catheter- Induced Errors in Pressure Measurements in Vessels: An In-Vitro and Numerical Study. IEEE Trans Biomed Eng 2014;61:1844-50.
31.
30. Roos A. Poiseuille’s law and its limitations in vascular systems. Med Thorac 1962;19:224-38.
32.
31. Manes A, Palazzini M, Leci E, et al. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J 2014;35:716-24.